Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

  3. Amgen - Wikipedia

    en.m.wikipedia.org/wiki/Amgen

    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5]

  4. Products - Amgen

    www.amgen.com/products

    Amgens medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.

  5. Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla...

  6. We Are Biotech | Amgen

    www.amgen.com/splash-page

    Amgen's powerful research and development group uses cutting-edge tools like AI, generative biology and human data to discover and develop new types of medicines to fight the world's toughest diseases. Learn More.

  7. Investors | Amgen Inc.

    investors.amgen.com

    Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

  8. Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.

  9. US FDA approves Amgen drug for small cell lung cancer

    www.reuters.com/business/healthcare-pharmaceuticals/us-fda...

    The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung...

  10. Amgen quarterly profit rises 15%, obesity drug trials are on ...

    www.reuters.com/business/healthcare-pharmaceuticals/amgen...

    Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon...

  11. Amgen - LinkedIn

    www.linkedin.com/company/amgen

    Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry ...